Key Takeaways
- Intentional mix shift drove margin expansion: EBITDA margin rose to 13.4% in Q4 from 12.0% in Q3, even as revenue and volume declined, because the company deliberately replaced conventional-grade oils with higher-margin specialty products.
- Debt-free balance sheet achieved: All short-term debt was repaid during the year, making the company debt-free in a true sense, despite a sharp rise in finance costs from global rate hikes.
- Export resilience amid currency chaos: Export share climbed to 44% of sales in Q4, as the company expanded into newer markets to offset currency shortages, inflation, and recessionary concerns in existing customer countries.
- Capacity expansion on track, with more to come: Over 50% of the 30,000-ton capacity added in FY23 was commercialized in Q4, the balance is due in Q1 FY24, and another 30,000-ton expansion is planned for FY24.
- What to watch next quarter: Whether the 15% revenue growth target for FY24 begins to materialize, the pace of commercialization for the remaining new capacity, and any stabilization in finance costs and currency volatility.
Product Mix & Margin Strategy
- Deliberate volume sacrifice: Consolidated volume declined QoQ from 59,000 to 57,000 tons because the company intentionally reduced exposure to conventional-grade oils and replaced them with value-added specialty products, a trade-off that improved profitability.
- Mix shift quantified: The product mix improved in favor of value-added products to the tune of 68%, enabling the company to report healthy EBITDA margins of 13.4% in Q4 versus 12.04% in the preceding quarter.
- Per-ton margin opacity: When asked for per-ton margin figures, a metric the company historically discussed, management generalized across ~80 product grades into conventional and specialty categories and provided only EBITDA percentages, declining to give a per-ton number.
Hussein Rayani: "We are intentionally concising our exposure on the conventional grade of oils. And, of course, it is being replaced by more value-added products. So, the volume is not vis-à-vis the same. But overall, it has a good impact on the EBITDA margin..."
Financial Health & External Headwinds
- Finance cost surge: FY23 finance cost rose to ~₹10 crores from ~₹4 crores in FY22, driven by dramatic global interest rate hikes on floating-rate loans, a headwind the company absorbed while maintaining ~14% margins.
- Currency losses absorbed: A notional exchange loss of ~₹12 crores for the full year was driven by currency volatility, though the company mitigated some risks through inventory adjustments.
- Debt-free milestone: The company repaid all short-term debt and became debt-free in the true sense, a notable achievement in a year of rising rates.
- Revenue de-growth explained: Revenue fell from ₹572 crores in Q3 to ₹510 crores in Q4, and H2 was weaker than H1; management attributed both to volatile oil prices, harsh global interest rate increases, and the intentional shift away from conventional grades.
Export Performance & Market Diversification
- Export share expansion: Exports reached 44% of sales in Q4 FY23, up despite geopolitical challenges, currency shortages in some customer countries, and recessionary and inflationary concerns.
- Mitigation through market breadth: The company is mitigating export headwinds by increasing its presence in more global markets, rather than relying on a concentrated set of countries facing currency crises.
- Domestic demand strength: Good domestic demand with healthy realizations persisted through Q4, with particular strength observed in the textile segment for antistatic coning oil and circular knitting oils used in texturizing units.
Hussein Rayani: "On the export front, of course, there are concerns, more challenges because a lot of the countries are experiencing tremendous shortage of currency. There are inflationary and recessionary concerns and challenges. We are mitigating those risks by increasing our presence in more global markets."
Capacity Expansion & Commercialization
- FY23 capacity progress: More than 50% of the 30,000-ton capacity expansion added in FY23 was commercialized in Q4 FY23, with the balance expected to be commercialized in Q1 FY24 in a batch-wise process.
- FY24 expansion pipeline: An additional 30,000-ton expansion is planned for FY24 and is on due course as per plan, with all expansion plans described as on track.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Hopeful of 15% growth in revenues | FY24 |
| Capacity commercialization (balance) | Remaining portion of FY23's 30,000-ton expansion to be commercialized | Q1 FY24 |
| Further capacity expansion | Another 30,000-ton expansion on track | FY24 |
| Margin sustainability | Expect to sustain margins with more stability and normalcy giving better visibility | FY24 |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Consolidated operating income | ₹513.24 cr |
| Consolidated operating EBITDA | ₹69 cr |
| Operating EBITDA margin | 13.4%, up from 12.04% in Q3 FY23 |
| Consolidated net profit after tax | ₹50.81 cr |
| PAT margin | 9.9% |
| FY23 full-year consolidated operating income | ₹2,255.3 cr, up ~6% YoY |
| FY23 full-year consolidated PAT | ₹232.97 cr |
| FY23 full-year operating EBITDA margin | 13.99% (~14%), up ~4.3% YoY |
| Value-added products share of product mix | 68% |
| Consolidated volume | ~57,000 tons, down from ~59,000 tons in Q3 FY23 |
| Exports share of sales | 44%, increased from prior periods |
| FY23 full-year finance cost | ~₹10 cr, up from ~₹4 cr in FY22 |
| FY23 full-year notional exchange loss | ~₹12 cr |
| Capacity expansion commercialized in Q4 FY23 | More than 50% of 30,000 tons added |
| FY24 planned capacity expansion | 30,000 tons |
| Final dividend per share | ₹5, plus interim ₹3, totaling ₹8 per share (400%) |
| FY24 revenue growth guidance | 15% growth expected |